Metabolomics in Early-Phase Clinical Trials from 2010 to 2025
An international assessment of metabolomics integration in registered early-phase clinical trials provides an international assessment of metabolomics integration in registered early-phase clinical trials and concludes that metabolomics remains underutilised in early-phase clinical trials.